STAT

Months after a sexual harassment scandal, OrbiMed’s banking another billion

Months after being rocked by sexual harassment allegations, biotech’s largest investment fund is in process of raising $1 billion from investors, its largest offering to date, while the founder who was at the center of the controversy remains a partner at the firm.

Legendary biotech financier Sam Isaly said late last year that he would retire following publication of a STAT investigation in which six former OrbiMed employees said he regularly sexually harassed the firm’s female employees, particularly executive assistants.

But recent filings with the Securities. The Wall Street firm and Isaly are in the process of negotiating his departure, but it’s unclear how long those talks might take.

You're reading a preview, sign up to read more.

More from STAT

STAT5 min readSociety
After Ebola Spills Into Uganda, WHO Decides Against Emergency Declaration
The Ebola outbreak in the Democratic Republic of the Congo still doesn’t constitute a global health emergency, the WHO said Friday.
STAT3 min readSociety
Opinion: Shopping Blindly For Post-acute Care Is A Recipe For Disaster
The notion that sick, frail, or elderly patients and their families can somehow figure out on their own the best choice for post-acute care must be discarded.
STAT8 min readScience
‘It Felt Like An ’80s Criminal Drama’: What Happened When A Biohacker Met Bureaucrats Investigating Him
"If I can order this gene therapy online for under $500, there's maybe a little bit more we can do for people," says prominent biohacker Josiah Zayner.